Success Metrics

Clinical Success Rate
42.9%

Based on 3 completed trials

Completion Rate
43%(3/7)
Active Trials
1(11%)
Results Posted
133%(4 trials)
Terminated
4(44%)

Phase Distribution

Ph phase_4
1
11%
Ph phase_3
5
56%
Ph not_applicable
2
22%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
5(55.6%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(3)
Terminated(4)
Other(1)

Detailed Status

Terminated4
Completed3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
42.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 35 (55.6%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

recruiting111%
terminated444%
completed333%
unknown111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_4

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

NCT06076304
completedphase_3

Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media

NCT02630992
completedphase_1

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

NCT00354965
terminatedphase_3

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

NCT01110408
terminatedphase_3

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

NCT01110382
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06076304Phase 4

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

Recruiting
NCT02630992Phase 3

Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media

Completed
NCT00354965Phase 1

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Completed
NCT01110408Phase 3

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Terminated
NCT01110382Phase 3

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Terminated
NCT01110421Phase 3

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Terminated
NCT00445497Phase 3

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Unknown
NCT00062231Not Applicable

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Terminated
NCT00135603Not Applicable

Antibiotic Therapy Versus Appendectomy for Acute Appendicitis

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9